Long-term retention rate of pramipexole in the treatment of Parkinson’s disease

被引：0
作者：
Tapani Keränen
Mervi Tuhkasaari
Hanna Kuusisto
机构：
[1] Tampere University Hospital,Division of Neurology and Rehabilitation
[2] University of Kuopio,Department of Pharmacology and Toxicology
来源：
European Journal of Clinical Pharmacology | 2009年 / 65卷
关键词：
Outcome; Parkinson’s disease; Pramipexole; Retention rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：955 / 956
页数：1
相关论文
共 18 条
[1]  
Arbouw MEL(2008)Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials Eur J Clin Pharmacol 64 1021-1026
[2]  
Movig KLL(1958)Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457-481
[3]  
Guchelaar H-J(1972)Regression models and life tables J Roy Stat Soc 34 187-220
[4]  
Poels PJE(2001)The long-term safety and efficacy of pramipexole in advanced Parkinson’s disease Parkinsonism Relat Disord 7 115-120
[5]  
van Vugt JPP(2005)Long-term efficacy and safety of pramipexole in advanced Parkinson’s disease: results from a European multicenter trial Mov Disord 20 602-610
[6]  
Neef C(undefined)undefined undefined undefined undefined-undefined
[7]  
Egberts TC(undefined)undefined undefined undefined undefined-undefined
[8]  
Kaplan EL(undefined)undefined undefined undefined undefined-undefined
[9]  
Meier P(undefined)undefined undefined undefined undefined-undefined
[10]  
Cox DR(undefined)undefined undefined undefined undefined-undefined
12